7th International Symposium on Solid Oral Dosage Form

Solid Oral Dosage Forms

Who should attend

The symposium is intended for people concerned with design, production and quality assurance of solid oral dosage forms and who are interested in increasing their knowledge in this important field of the pharmaceutical sciences. The program has a scientific focus and topics of interest for the industry and researchers within the academic community will be addressed.

The Program

The program starts Sunday April 7, 16.00 hrs and contains 4 speaker sessions over three days. On Monday April 8, the symposium starts at 08.45 hrs with registration from 08.00 hrs. The program ends April 9 approximately 15.45 hrs. The official language is English.
The following sessions and speakers are part of the program:

Sunday April 7

Registration & Poster mounting

Opening of the Conference

Introductary lectures:

Plenary: Coated formulations to achieve controlled release
Anette Larsson, Chalmers University of Technology, Sweden

Challenges and oppurtunities in future Drug Delivery
Jonas Johansson, AstraZeneca Gothenburg, Sweden
Christina Erixon, APL, Sweden

Poster Session and Exhibition with Welcome Mingle (foood and drinks)

Monday April 8

Introductary lectures continues:
Plenary: Case Studies from an Academic Perspective in Switching from Batch to Continuous
Pharmaceutical Drug Product Manufacturing
Thomas de Beer, Ghent University

Session 1: Material Science Tetrahedron
Advances in amorphous drug formulation
Eric Ofosu Kissi, University of Oslo, Norway,

Plenary: Crystal Engineering: Then and Now
Mike Zaworotko, University of Limerick, Ireland,

3D/4D quantitative studies of pharmaceutical materials using x-ray microtomography
Fredrik Forsberg, Luleå University of Technology, Sweden

Characterization of solid dosage forms by ToF-SIMS
Mark Nicholas, AstraZeneca Gothenburg, Sweden

Session 2: Manufacturing – process understanding and control
Additive manufacturing of personalized pharmaceuticals
Jukka Rantanen, University of Copenhagen, Denmark

Challenges for continuous manufacturing in pharmaceutical industry
Pirjo Tajarobi/Håkan Wikström, AstraZeneca Gothenburg, Sweden

Tools for analysing and predicting powder compression and compaction properties
Göran Adlerborn, Uppsala University, Sweden

Real Time Prediction of Tablet Dissolution
Robert Zuban, Sartorius-Stedim

The next step in Mesoporous silica formulation strategies : Dry Amorphisation
Fred Monsour, Grace Material Technologies

Symposium dinner

Tuesday April 9

Session 3: Biopharmacy
Plenary: Impact of gastrointestinal variabilities on in vivo drug product performance in special
patient groups
Sandra Klein, Ernst-Moritz-Arndt-Universität Greifswald,Germany

New tools to delineate processes important for absorption from enabling oral dosage forms
Christel Bergström, Uppsala University, Sweden

Nanoparticles, colloidal structures and hydrodynamics-combined effects in intestinal drug absorption
Erik Sjögren, Uppsala University and Pharmetheus, Sweden

Disintegration of IR tablets: Comparison of fasted and fed state and robustness of
tablet formulation
Peter Langguth, Johannes Gutenberg University, Mainz, Germany

Session 4: New oppurtunities and regulatory aspects
Plenary: Regulatory handling of novel manufacturing principles
Øyvind Holte, Norwegian Medical Agency, Norway

Enhancement of Quality Control Procedures – A case study
Anders Karlsson, AstraZeneca Gothenburg, Sweden

Development of oral dispersible and chewable tablets -with a focus on the advantages of co-processed excipients
Mark Plunkett, Fuji Chemical Industries Co. Ltd, Sweden

Abstract information

The symposium includes a poster session to which all delegates may apply. PhD/Postdocs/Graduate students and delegates are encouraged to submit their poster abstract.Final date for submission has passed but if you still wish to submitt an abstract this is possible. Based on submitted poster abstracts a few presenters will be offered to make an oral presentation of their work.The poster abstract should be sent as a word document to lovisa.andersson@lakemedelsakademin.se Kindly indicate if you wish to speak when submitting the abstract.
Posterabstract instructions
Instructions for preparation of a poster

Partners/exhibitors

This sympsoium has the following partners who also will be exhibiting: Dow, AstraZeneca, Galenica, Recipharm, APL, Fujichemical, Sartorius and BASF.

Venue and dinner

The meeting will take place at AstraZeneca in Mölndal. It starts Sunday April 7 at 16.00 hrs with registration, mingle and lectures. On Monday April 8, the symposium starts at 08.45 hrs with registration from 08.00 hrs. The program ends April 9, approximately 15.45 hrs.

A Sympsoium dinner will be held April 8 at AstraZeneca at 18.30 hrs. The fee is 350 SEK and needs to be pre-booked when signing up for the symposium.

Hotel reservation

Hotel Scandic Mölndal near our venue, offer good prices for delegates to this Sympsoium. To book a room call: 004631-7515200 and choose individual booking.  To be able to get the lower price for a room, please use the following booking number LAE070419.

To be able to get a good price on the room kindly book latest one month prior to the symposium.

Participation fees, notification and cancellation

The participation fees for Industry delegates is 5000 SEK, for Academic delegates 3500 SEK and for PhD delegates 2000 SEK before March 7, 2019. Included in the fees are cffee/tea and lunches. The symposium dinner fee is 350 SEK. All prices are excluding VAT. Early fee is valid until February 15. From February 16 a late fee will be added with 500 SEK on all categories

Program Committee

Susanna Alami Abrahamsén, AstraZeneca Gothenburg
Jessica Elversson, Galenica
Christina Erixon, APL
Göran Frenning, Umeå University
Sophie Hoas, Swedish Academy of Pharmaceutical Science
Sofia Mattsson, Umeå University
Sitaram Velaga, Luleå Technical University
Lisa Bandholz, Swedish Pharmaceutical Society